Literature DB >> 12815111

The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults.

Markus Schmugge1, Margaret Lucille Rand, Kyong Won Annie Bang, Meera Mody, Michael Stephen Dunn, Kofi Sarpong Amankwah, Victor Stanley Blanchette, John Freedman.   

Abstract

von Willebrand Factor (VWF) is important in platelet adhesion and shear-dependent platelet activation. We performed flow cytometric analyses of VWF binding to and activation of platelets from healthy neonates, children, and adults. Platelets from cord blood (n = 38; gestational age: 36-42 wk; birth weight: 2.4-5.1 kg), neonatal venous blood (n = 19; d 2-3 of life), children (n = 15; age: 1.5-16.3 y), and adults (n = 22; age: 18-55 y) were studied. Binding of VWF was assessed using an antihuman VWF polyclonal antibody and a FITC-conjugated secondary antibody. Platelet activation was determined by the expression of CD62P, CD63, CD41, CD42b, activated GPIIb/IIIa (PAC-1), procoagulant surface (as reflected by annexin V binding), and microparticle formation. Although the mean percentage of VWF-positive platelets was not significantly higher in unstimulated platelets from 2- to 3-d-old neonates, their platelets were more activated than those from adults, and there was a positive correlation of VWF binding with platelet activation (CD62P: r = 0.74, p < 0.001; annexin V: r = 0.46, p < 0.05). In adults, after in vitro activation of platelets with thrombin and ADP, VWF binding to platelets increased and correlated significantly with CD62P expression (r = 0.71, p < 0.001). VWF binding to unstimulated neonatal platelets was, however, higher than that to in vitro-stimulated platelets from adults at the same level of expression of platelet activation markers. Further studies are required to assess the mechanism and significance of VWF binding to activated platelets in the neonatal period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815111     DOI: 10.1203/01.PDR.0000081294.26060.4B

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression.

Authors:  Hideki Nakayama; Kenji Ihara; Shunji Hikino; Junko Yamamoto; Taro Nagatomo; Megumi Takemoto; Toshiro Hara
Journal:  J Mol Med (Berl)       Date:  2005-01-13       Impact factor: 4.599

2.  Assessment of neonatal platelet adhesion, activation, and aggregation.

Authors:  S M Baker-Groberg; S Lattimore; M Recht; O J T McCarty; K M Haley
Journal:  J Thromb Haemost       Date:  2016-03-16       Impact factor: 5.824

Review 3.  A review of the role of extracellular vesicles in neonatal physiology and pathology.

Authors:  Claire A Murphy; Daniel P O'Reilly; Elaine Neary; Afif El-Khuffash; Fionnuala NíAinle; Naomi McCallion; Patricia B Maguire
Journal:  Pediatr Res       Date:  2020-11-12       Impact factor: 3.756

4.  Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.

Authors:  Athina Pappas; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef C Cortez; Gaurav Bhatti; Nardhy Gomez-Lopez; Sonia S Hassan; Seetha Shankaran; Adi L Tarca
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.

Authors:  Yesica Garciafigueroa; Brett E Phillips; Carl Engman; Massimo Trucco; Nick Giannoukakis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

Review 6.  The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs.

Authors:  Claire A Murphy; Elaine Neary; Daniel P O'Reilly; Sarah Cullivan; Afif El-Khuffash; Fionnuala NíAinle; Patricia B Maguire; Naomi McCallion; Barry Kevane
Journal:  Eur J Pediatr       Date:  2021-07-20       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.